critically ill patient

危重患者
  • 文章类型: Journal Article
    提供标准化、对危重病人来说,高质量的康复是一个至关重要的问题。2017年,日本重症监护医学学会(JSICM)颁布了“重症监护病房早期康复循证专家共识”,以倡导在日本重症监护机构中尽早开始康复。在这项开创性工作的基础上,JSICM最近利用建议分级进行了严格的系统审查,评估,发展,和评估(等级)方法。这一努力导致了临床实践指南(CPG)的制定,旨在阐明早期ICU康复的最佳实践。本指南的主要目的是增强临床理解,从而促进基于证据的决策。最终有助于提高重症监护患者的预后。世界上以前的CPG没有专门针对危重病人的康复,使用等级方法。多学科合作在康复中极为重要。因此,CPG是由一个由工作组组成的准则发展小组的73名成员制定的,一个系统的审查小组,和一个学术指南推广小组,以JSICM为核心的重症监护早期动员和康复临床实践指南委员会。许多成员为准则的制定做出了贡献,包括具有多个和不同专业的医生和医疗保健专业人员,以及ICU患者。根据小组成员之间的讨论,确定了本CPG的8个重要临床重点领域.然后为每个领域制定了十四个重要的临床问题(CQs)。公众被邀请发表两次评论,对CQ的回答以10个GRADE建议和对四个背景问题的评论的形式提出。此外,每个CQ的信息已被创建为视觉临床流程,以确保每个CQ的定位可以很容易地理解。我们希望CPG将成为多种职业的重症患者康复的有用工具。
    Providing standardized, high-quality rehabilitation for critically ill patients is a crucial issue. In 2017, the Japanese Society of Intensive Care Medicine (JSICM) promulgated the \"Evidence-Based Expert Consensus for Early Rehabilitation in the Intensive Care Unit\" to advocate for the early initiation of rehabilitations in Japanese intensive care settings. Building upon this seminal work, JSICM has recently conducted a rigorous systematic review utilizing the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. This endeavor resulted in the formulation of Clinical Practice Guidelines (CPGs), designed to elucidate best practices in early ICU rehabilitation. The primary objective of this guideline is to augment clinical understanding and thereby facilitate evidence-based decision-making, ultimately contributing to the enhancement of patient outcomes in critical care settings. No previous CPGs in the world has focused specifically on rehabilitation of critically ill patients, using the GRADE approach. Multidisciplinary collaboration is extremely important in rehabilitation. Thus, the CPGs were developed by 73 members of a Guideline Development Group consisting of a working group, a systematic review group, and an academic guideline promotion group, with the Committee for the Clinical Practice Guidelines of Early Mobilization and Rehabilitation in Intensive Care of the JSICM at its core. Many members contributed to the development of the guideline, including physicians and healthcare professionals with multiple and diverse specialties, as well as a person who had been patients in ICU. Based on discussions among the group members, eight important clinical areas of focus for this CPG were identified. Fourteen important clinical questions (CQs) were then developed for each area. The public was invited to comment twice, and the answers to the CQs were presented in the form of 10 GRADE recommendations and commentary on the four background questions. In addition, information for each CQ has been created as a visual clinical flow to ensure that the positioning of each CQ can be easily understood. We hope that the CPGs will be a useful tool in the rehabilitation of critically ill patients for multiple professions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:已经研究了β受体阻滞剂在危重病中的作用,在过去的二十年中,有关这些药物对危重病人的保护作用的数据已在文献中反复报道。然而,在危重患者中使用β受体阻滞剂的问题上,科学团体仍缺乏共识和指南.本文件的目的是支持危重患者使用β受体阻滞剂的临床决策过程。这份文件的接受者是医生,护士,医护人员,以及其他参与患者护理过程的专业人员。
    方法:意大利麻醉学会,镇痛,复苏和重症监护(SIAARTI)选择了一个专家小组,并要求他们定义在危重成年患者中使用β受体阻滞剂的关键方面。专家在此过程中遵循的方法符合改良的Delphi和RAND-UCLA方法的原则。专家们以翔实的文字形式提出了声明和支持性理由。发言的总体清单遭到盲目投票以达成共识。
    结果:文献检索表明,危重患者的肾上腺素能应激和心率增加与器官功能障碍和死亡率增加有关。因此,心率控制在危重病人的管理中似乎至关重要。需要针对继发性心动过速的鉴别诊断和节律紊乱的治疗进行仔细的临床评估。此外,在排除低血容量后,脓毒性休克患者可考虑使用β受体阻滞剂治疗持续性心动过速.静脉给药应该是首选的给药途径。
    结论:β受体阻滞剂对危重患者的保护作用已在文献中反复报道。它们在心率加快的急性治疗中的使用需要了解病理生理学和仔细的鉴别诊断。因为心动过速的所有原因都应该首先排除和解决。
    BACKGROUND: The role of β-blockers in the critically ill has been studied, and data on the protective effects of these drugs on critically ill patients have been repeatedly reported in the literature over the last two decades. However, consensus and guidelines by scientific societies on the use of β-blockers in critically ill patients are still lacking. The purpose of this document is to support the clinical decision-making process regarding the use of β-blockers in critically ill patients. The recipients of this document are physicians, nurses, healthcare personnel, and other professionals involved in the patient\'s care process.
    METHODS: The Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) selected a panel of experts and asked them to define key aspects underlying the use of β-blockers in critically ill adult patients. The methodology followed by the experts during this process was in line with principles of modified Delphi and RAND-UCLA methods. The experts developed statements and supportive rationales in the form of informative text. The overall list of statements was subjected to blind votes for consensus.
    RESULTS: The literature search suggests that adrenergic stress and increased heart rate in critically ill patients are associated with organ dysfunction and increased mortality. Heart rate control thus seems to be critical in the management of the critically ill patient, requiring careful clinical evaluation aimed at both the differential diagnosis to treat secondary tachycardia and the treatment of rhythm disturbance. In addition, the use of β-blockers for the treatment of persistent tachycardia may be considered in patients with septic shock once hypovolemia has been ruled out. Intravenous application should be the preferred route of administration.
    CONCLUSIONS: β-blockers protective effects in critically ill patients have been repeatedly reported in the literature. Their use in the acute treatment of increased heart rate requires understanding of the pathophysiology and careful differential diagnosis, as all causes of tachycardia should be ruled out and addressed first.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:关于危重患者撤除肾脏替代疗法(RRT)的适当时机的临床决策是复杂且多因素的。当前研究的目的是使用共识聚类分析来确定哪些患有急性肾损伤(AKI)的重症患者更有可能成功地脱离RRT。方法:在本研究中,纳入2016年8月至2018年7月在三家多中心转诊医院的几个时间点接受RRT的危重患者。使用无监督的共识聚类算法来识别不同的表型。感兴趣的结果是戒断RTT的能力和90天死亡率。结果:共纳入124例需要RRT(AKI-RRT)的AKI患者。90天死亡率为30.7%(38/124),49.2%(61/124)的患者成功断奶RRT超过90天。一致性聚类算法从总共45个特征中识别出三个聚类。三个簇具有不同的特征,可以根据尿中性粒细胞明胶酶相关脂质运载蛋白与肌酐之比(uNGAL/Cr)的组合进行分离。序贯器官衰竭评估(SOFA)评分,和RRT断奶时估计的肾小球滤过率。uNGAL/Cr(风险比[HR]2.43,95%置信区间[CI]:1.36-4.33)和聚类表型(聚类1与3,HR2.7,95%CI:1.11-6.57;第2组vs.3,HR44.5,95%CI:11.92-166.39)可以预测90天的死亡率或再透析。结论:几乎一半的AKI-RRT危重患者可以在90天内停止透析。尿NGAL/Cr和不同的聚集表型可以预测90天的死亡率或再透析。
    Background: Clinical decisions regarding the appropriate timing of weaning off renal replacement therapy (RRT) in critically ill patients are complex and multifactorial. The aim of the current study was to identify which critical patients with acute kidney injury (AKI) may be more likely to be successfully weaned off RRT using consensus cluster analysis. Methods: In this study, critically ill patients who received RRT at three multicenter referral hospitals at several timepoints from August 2016 to July 2018 were enrolled. An unsupervised consensus clustering algorithm was used to identify distinct phenotypes. The outcomes of interest were the ability to wean off RTT and 90-day mortality. Results: A total of 124 patients with AKI requiring RRT (AKI-RRT) were enrolled. The 90-day mortality rate was 30.7% (38/124), and 49.2% (61/124) of the patients were successfully weaned off RRT for over 90 days. The consensus clustering algorithm identified three clusters from a total of 45 features. The three clusters had distinct features and could be separated according to the combination of urinary neutrophil gelatinase-associated lipocalin to creatinine ratio (uNGAL/Cr), Sequential Organ Failure Assessment (SOFA) score, and estimated glomerular filtration rate at the time of weaning off RRT. uNGAL/Cr (hazard ratio [HR] 2.43, 95% confidence interval [CI]: 1.36-4.33) and clustering phenotype (cluster 1 vs. 3, HR 2.7, 95% CI: 1.11-6.57; cluster 2 vs. 3, HR 44.5, 95% CI: 11.92-166.39) could predict 90-day mortality or re-dialysis. Conclusions: Almost half of the critical patients with AKI-RRT could wean off dialysis for over 90 days. Urinary NGAL/Cr and distinct clustering phenotypes could predict 90-day mortality or re-dialysis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • DOI:
    文章类型: Consensus Development Conference
    Eighty to 90% of patients attended in emergency departments are discharged to home. Emergency department physicians are therefore responsible for specifying how these patients are treated afterwards. An estimated 30% to 40% of emergency patients have diabetes mellitus that was often decompensated or poorly controlled prior to the emergency. It is therefore necessary to establish antidiabetic treatment protocols that contribute to adequate metabolic control for these patients in the interest of improving the short-term prognosis after discharge. The protocols should also maintain continuity of outpatient care from other specialists and contribute to improving the long-term prognosis. This consensus paper presents the consensus of experts from 3 medical associations whose members are directly involved with treating patients with diabetes. The aim of the paper is to facilitate the assessment of antidiabetic treatment when the patient is discharged from the emergency department and referred to outpatient care teams.
    El 80-90% de los pacientes atendidos en los servicios de urgencias son dados de alta desde los mismos, y por tanto los facultativos de urgencias son los responsables del tratamiento al alta en dichos pacientes. Se estima que la frecuencia de diabetes mellitus en urgencias es de un 30-40% y en muchos casos dicha diabetes está descompensada o con un mal control metabólico previo, por lo que es necesario establecer pautas de tratamiento antidiabético adecuadas de cara al alta que contribuyan a un adecuado control metabólico de dichos pacientes y favorezca un mejor pronóstico a corto plazo tras el alta, así como mantener una continuidad con la atención ambulatoria por parte de otras especialidades y contribuir a una mejoría del pronóstico a largo plazo. El presente documento es por tanto un consenso de expertos de tres sociedades científicas implicadas directamente en la atención del paciente diabético, que pretende facilitar la valoración del tratamiento al alta desde urgencias en cuanto a la diabetes se refiere y su continuidad asistencial ambulatoria.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号